enzyme-linked immunosorbent assay with sera from Lyme disease patients as well as syphilitic and normal sera. Immunoglobulin G antibody from Lyme disease patient sera reacted predominantly with the central portion of the protein. The region of the flagellin protein encompassing amino acids 64 to 311 detected nearly all of the immunoglobulin G-positive Lyme sera and only reacted with 1 of 26 syphilis patient serum samples.
In contrast, 12 of 26 syphilis patient serum samples and 2 of 47 normal serum samples reacted with the amino terminus of the flagellin protein, whereas 4 of 26 syphilis patient serum samples and 7 of 47 normal serum samples reacted with the carboxyl terminus. The central region containing amino acids 64 to 311 may be employed diagnostically to differentiate antibodies to B. burgdorferi from antibodies to Treponema pallidum. In addition, this region also was recognized by immunoglobulin M in the Lyme patient sera, indicating its potential usefulness as a marker for early Lyme disease.
Lyme disease is a multisystem illness caused by the tick-transmitted spirochete Borrelia burgdorferi (5, 21) . Lyme borreliosis is the most common arthropod-borne infection in the United States and has been reported in many countries throughout Asia and Europe (2, 21) . The early clinical feature of this disease is a local infection of the skin, erythema migrans, which may be followed by the development of systemic disease involving the nervous system, heart, or joints (2, 21) .
Culture of the spirochete from human body fluids and antigen detection methods often are falsely negative, leading to misdiagnosis of Lyme disease (2, 21) . Currently, serological methods to detect antibodies to B. burgdorferi are the most appropriate means to diagnose infection or exposure. Commonly used assays for the diagnosis of Lyme disease include the indirect immunofluorescence assay, enzymelinked immunosorbent assay (ELISA), and Western immunoblot, which has been shown to be more sensitive than the immunofluorescence assay or the ELISA for the detection of early disease (11) . However, analysis of Western blot reactivity is subjective with regard to band intensity; clear criteria for blot interpretation are difficult to establish (25).
Most ELISAs for Lyme disease utilize whole or sonicated B. burgdorferi cells as the test antigen, although several investigators demonstrated improved performance of these immunoassays when subcellular fractions of the spirochete were used (6, 8, 13, 15) .
The B. burgdorferi flagellar protein, flagellin, is highly immunogenic and generally elicits the earliest detectable immune response after infection (6, 11) . Flagellin-enriched fractions of B. burgdorferi have been shown to improve the performance of Lyme antibody assays (12, 13 the specificity of these assays may be reduced because of cross-reactivity of the B. burgdorferi flagellin with the flagella of other spirochetes, most notably with Treponema pallidum, the causative agent of syphilis (16) . It also has been demonstrated that antibodies to oral spirochetes associated with gingivitis or periodontitis can react in serological assays for Lyme disease (17) . Cross-reactivity with sera from these patients can be reduced by adsorption of the patient sera with the Treponema Reiter strain (17, 24) , but this also can reduce the sensitivity of the Lyme antibody assays.
The nucleotide and amino acid sequences have been determined for the flagellin proteins of several B. burgdorferi isolates (7, 9, 23 (20) to verify fidelity of amplification.
Expression and purification of recombinant proteins. Bacterial clones expressing flagellin proteins were grown overnight at 37°C in a rich medium (32 g of tryptone per liter, 20 g of yeast extract per liter, 5 g of NaCl per liter, 3 mM glucose) containing ampicillin (50 ,ug/ml) and tetracycline (50 ,ug/ml). The overnight cultures were diluted 1:10 into the same medium and incubated at 37°C with aeration until the culture reached an optical density at 600 nm of 1.0 and then induced by the addition of isopropyl-,-D-thiogalactopyranoside (IPTG; final concentration, 1 mM; Sigma). After incubation for 4 h, the cells were harvested by centrifugation at 12,000 x g (4°C) for 15 min. Samples of preinduced and induced cells were analyzed for recombinant protein production by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described below.
To purify the recombinant proteins, the cells were lysed by suspension and sonication in TE buffer (50 mM Tris, 10 mM EDTA [pH 8.5]) containing 1 mg of lysozyme per ml, 100 ,ug of DNase per ml, and 0.5% Triton X-100. The cell lysate was centrifuged at 25,000 x g for 30 min, and the recombinant proteins were recovered in the pellet. Soluble E. coli proteins were removed from the pellet by washing in TE buffer containing 5% Triton X-100, TE buffer containing 1% sodium deoxycholate, and then TE buffer containing 0.5 M NaCl. After a water wash, the insoluble pellet containing the recombinant fusion protein was solubilized in TE buffer containing 8 M urea and 1 mM dithiothreitol and stored at 40C.
The expression levels and purities of the recombinant proteins were evaluated by SDS-PAGE as described by Laemmli (14) with 12% acrylamide running gels and 5% acrylamide stacking gels. Samples were suspended in loading buffer (final concentrations: 62.5 mM Tris, 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, and 0.1 mg of bromophenol blue per ml) and boiled for 2 min. Gels were stained in a solution of 0.125% Coomassie blue dye in 50% methanol and 10% acetic acid for 1 patients with Lyme disease (Lyme disease sera) used in this study. B. burgdorferi was denatured in SDS-PAGE loading buffer, and a volume containing 7.5 mg wet weight of cells was electrophoresed into 12% acrylamide gels (13 by 13 cm). The separated proteins were electrophoretically transferred to nitrocellulose sheets (Bio-Rad Laboratories, Richmond, Calif.) at 700 mA for 45 min in buffer consisting of 25 mM Tris (pH 8.3)-192 mM glycine-20% methanol (22) , blocked overnight in 100 mM Tris-135 mM NaCl (TBS) containing 3% gelatin, and cut into 3-mm-wide strips. Serum samples were diluted 1:50 in a diluent consisting of 100 mM Tris (pH 7.5), 135 mM NaCl, 10 mM EDTA, 0.2% Tween 20, and 4% fetal calf serum (GIBCO, Grand Island, N.Y.) and allowed to react with the nitrocellulose strips for 2 h. After a wash with TBS, the antibody-antigen reactions were detected by incubation with peroxidase-labelled goat anti-human immunoglobulin G (IgG; b-chain specific) or anti-human IgM (,u-chain specific) conjugates (Kirkegaard and Perry Laboratories, Gaithersburg, Md.) diluted to 0.5 ,ug/ml in a diluent consisting of 100 mM Tris (pH 7.5), 135 mM NaCl, and 10% fetal calf serum. The nitrocellulose was washed with TBS containing 0.05% Tween 20, and bound conjugate was detected by incubation in TBS containing 2 mg of 4-chloro-1-napthol per ml, 0.02% hydrogen peroxide, and 17% methanol. Immunoblots were considered to be positive for IgG if at least five proteins were reactive and three or more proteins were from the group consisting of the 18-, 31-, 34-, 41-, 60-, 66-, or 83-kDa proteins. An IgM immunoblot was considered positive if at least three proteins were reactive and two or more of the reactive proteins were from the group of proteins listed above.
ELISA. Purified recombinant antigens were diluted to 1 to 5 ,ug/ml in 50 mM carbonate buffer (pH 9.6), and 100 p1l was added to microtiter plate wells (MaxiSorp; Nunc, Inc., Naperville, Ill.). The plates were incubated in the antigen solution for 1 h at 370C and overcoated in a solution consisting of 10% fetal calf serum and 3% gelatin in phosphate-buffered saline for 30 min. Serum samples were diluted 1:200 in the same antibody diluent used for the Western blots, except 2% E. coli pTB210 lysate was added. Portions (100 pl) of each diluted serum sample were added to the microtiter wells and incubated for 1 h at 37°C; then the plates were washed three times with phosphate-buffered saline containing 0.05% Tween 20. Bound Ig was detected by incubation with peroxidase-labelled goat anti-human IgG or anti-human IgM conjugates as described above. After 1 h of incubation (370C) with 100 pl of the desired conjugate per well, the plate was washed as described above. The peroxidase substrate (0.02% hydrogen peroxide containing 2.5 mg of o-phenylenediamine dihydrochloride per ml) was allowed to react for 5 min at room temperature, and then the reaction was stopped by the addition of 1 N H2SO4. The A490 was read. The cutoff point for a positive result for each antigen was determined to be the mean of results from a normal population of 20 individuals with no known history of spirochetal infection plus 0.13 A490 unit.
The pTB210 lysate was included in the serum diluent to block any possible serum reactivity with the CKS portion of the fusion protein or with any E. coli proteins remaining associated with the purified recombinant proteins. This lysate was prepared by sonicating E. coli cells containing the pTB210 vector plasmid in lysis buffer as described above and retaining the supernatant after centrifugation at 25,000 x g for 30 min.
RESULTS
Expression of the flagellin protein and fragments. The amino acid sequence of the B. burgdorferi B31 flagellin protein (23) was aligned with the amino acid sequence of the T. pallidum endoflagellar subunit FlaB2 protein (19) by using the PALIGN program (PC-Gene; Intelligenetics, Inc., Mountain View, Calif.). There are 38% identical residues between the two sequences. When conservative changes are included, the two sequences are 51% homologous. The homology is greatest at the amino and carboxyl termini of the proteins, with the central region displaying the most variability.
We cloned the B. burgdorferi full-length fla gene and four gene fragments chosen on the basis of sequence homology with the T. pallidum endoflagellar protein ( Fig. 2 ; regions cloned are designated according to their amino acid residue endpoints). The regions were expressed as CKS fusion proteins under the control of a modified lac promoter as described by Bolling and Mandecki (4) . SDS-PAGE analysis of expression of each of the cloned fusion proteins before and after induction with IPTG ( Fig. 3) The patterns of ELISA IgG reactivity of the 83 Lymepositive serum specimens with the flagellin fusion proteins are outlined in Table 2 . Twenty-eight serum specimens were reactive with all of the flagellin regions, whereas the other sera failed to react with one or more of the regions. Nine of the specimens were unreactive with all of the flagellin antigens. Thirty-four serum specimens reacted with the full-length flagellin recombinant protein (pl-336) and the central regions of the protein (pl37-262 and p64-311) but did not react with the amino terminus (pl-137) and/or the carboxyl terminus (p262-336). Four of the serum specimens that were unreactive with the full-length flagellin recombinant The central regions of flagellin offer the apparent advantage of being unreactive with potential cross-reactive sera. None of the syphilitic sera was reactive with the recombinant flagellin proteins in the IgM assay, and only minor reactivity with proteins pl-336 and pl-137 occurred with the normal sera.
DISCUSSION
In this paper we describe the cloning, expression, and diagnostic utility of regions of the B. burgdorferi flagellin protein, which may be employed to improve the specificity of detection of antibodies against B. burgdorferi. Flagellin elicits an early and strong immune response in infected individuals (6, 8) . Hansen et al. (12) demonstrated that a flagellum-based ELISA was more sensitive and specific than the ELISA with a whole-cell sonic extract as the antigen in the serodiagnosis of Lyme disease; this observation was confirmed by Karlsson et al. (13) .
The flagellin proteins from three strains of B. burgdorferi, B31 (23), GeHo (9), and CA12 (7), have been cloned and sequenced. The amino acid sequences of the flagellin proteins from the European strain GeHo and the American strain CA12 (California) are identical, whereas the American strain B31 (New York) has alternate residues at positions 180 (threonine for asparagine) and 279 (asparagine for aspartic acid). Conservation of the flagellin sequence is one feature that makes this protein an attractive target for use as an antigen in a serological assay. However, there also is considerable homology between the flagellin of B. burgdorferi and the flagellar proteins of other bacterial species, including (9, 23) and that some of these sera contained antibodies to oral treponemes associated with periodontal infections (17) . However, normal sera were clearly differentiated from Lyme sera by using the p137-262 and p64-311 proteins. Wallich The IgM titers to T. pallidum in these sera were not determined, so additional sera from patients with primary syphilis and known IgM titers will be evaluated.
The observation that the central domain of the flagellin protein is the predominant epitope for the detection of IgM agrees with observations on the secondary structure of the flagellum filaments (18) . X-ray fiber diffraction analysis of the secondary flagellin structure indicated that the terminal portions of the protein influence the structure of the filament and are located toward the center of the filament, whereas the central region of the protein is not involved in conformation and is located on the outside of the filament structure. Wallich et al. (23) postulated that this exposed middle domain could function to elicit the immune response to B. burgdorferi. The utility of the central region of the B. burgdorferi flagellin protein as an antigen in serologic assays for Lyme disease was evaluated. The benefit derived by the use of this region in the IgG ELISA assay was in increased specificity; there was little or no cross-reactivity with syphilitic or normal sera. In the IgM ELISA, the central flagellin region displayed greater reactivity with Lyme sera than the fulllength protein did, leading to a more sensitive assay for the possible detection of early disease. Additional Lyme disease-specific proteins are currently being cloned and evaluated to complement the specific flagellin regions to detect Lyme disease sera that are not reactive with the flagellin protein.
We greatly appreciate the letter of Dr. Schneider et al. regarding the specificity of epitopes located on the flagellin protein of Borrelia burgdorferi, and we regret our failure to include their key study (6) in the discussion of our data. 280 , is fully contained within the B. burgdorferi-specific flagellin fragnent, p137-262. We selected and cloned the p137-262 region because of its lack of overall (13%) sequence homology with the Treponema pallidum endoflagellar subunit FlaB2 and because the homology is scattered throughout the sequence. On either side of the p137-262 polypeptide, the homology increases, as does the likelihood of immunological cross-reactivity.
Our serological evaluation of the cloned full-length B. burgdorferi flagellin and selected regions indicated that syphilitic and normal sera reactive with the full-length protein also were reactive with either the amino-terminal (pl-137) or the carboxyl-terminal (p262-336) region but not with the central region. We believe that these data agree with the data of Schneider et al. The shared overlap between peptide amino acids 121 to 148 and fragment pl-137 and that between peptide amino acids 255 to 280 and fragment p262-336 are regions of high homology with the T. pallidum flagellin and may explain the immunological cross-reactivity of syphilitic and normal sera with these sequences.
The inclusion of the Escherichia coli sonicate in the serum dilution buffer was not included to preabsorb antibodies directed to E. coli flagellar proteins which might cross-react with B. burgdorfen flagellin. Rather, the sonicate was included as a precaution to absorb antibodies reactive with the CMP-2-keto-3-deoxyoctulosonic acid synthetase portion of the fusion protein or contaminating E. coli proteins or lipopolysaccharide remaining after the purification of the recombinant proteins. Experiments performed with crossreactive sera demonstrated that the added sonicate did not play a major role in improving assay specificity. Also, note that the B. burgdorferi flagellin region p137-262 displays only limited homology with E. coli flagella, similar to that of T. pallidum (4) .
We previously demonstrated that the flagellin-specific monoclonal antibody H9724 reacted with a synthetic peptide representing amino acids 196 to 225 (5a). This peptide was found to react with many of the Lyme disease sera from patients with late-stage disease, in agreement with Schneider et al. Berland et al. (1) also found that the immunodominant domain comprising amino acids 197 to 241 was bound by serum samples from 17 to 18 patients exhibiting manifestations of late-stage disease. In a subsequent study (3), they determined that the majority of sera from Lyme disease patients with arthritis and neuroborreliosis contained antibodies that bound to the region encompassing amino acids 208 to 225. However, we also observed that patients with arthritic manifestations had antibodies reactive with the region defined by amino acids 1 to 137, which agrees with the results obtained by Collins and Peltz (2). Jiang et al. (5) also demonstrated that in addition to the dominant epitopes in the central portion of flagellin, additional Lyme serum-reactive epitopes were identified in the amino-terminal region.
The specificity of serodiagnosis of Lyme disease will certainly be improved through the use of specific regions of the flagellin. The question remains regarding the ability of such a target to detect all cases of Lyme disease. Additional specific B. burgdorferi proteins such as OspA, OspC, the 39-kDa protein, and others will need to be-evaluated as to their role in the diagnosis of Lyme disease.
